Britt Skogseid
- Epidemiology top 0.2%
- Oncology top 0.5%
- Neurology top 0.1%
- Surgery top 5%
- Endocrinology, Diabetes and Metabolism top 1%
- Co-authors
- Kjell ÖbergBarbro ErikssonCatharina LarssonGöran ÅkerströmMagnus NordenskjöldJonas RastadDonald GranbergYusuke Nakamura
- Topics
- Neuroendocrine Tumor Research Advances (105 papers)Neuroblastoma Research and Treatments (58 papers)Lung Cancer Research Studies (46 papers)
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Britt Skogseid
128 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Epidemiology 5.3k
- Oncology 4.4k
- Neurology 3.8k
- Surgery 1.0k
- Endocrinology, Diabetes and Metabolism 986
Countries citing papers authored by Britt Skogseid
This map shows the geographic impact of Britt Skogseid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britt Skogseid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britt Skogseid more than expected).
Fields of papers citing papers by Britt Skogseid
This network shows the impact of papers produced by Britt Skogseid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britt Skogseid. The network helps show where Britt Skogseid may publish in the future.
Co-authorship network of co-authors of Britt Skogseid
This figure shows the co-authorship network connecting the top 25 collaborators of Britt Skogseid. A scholar is included among the top collaborators of Britt Skogseid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britt Skogseid. Britt Skogseid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 45 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study | 2 |
| 7 | 85 | |
| 8 | 58 | |
| 9 | 32 | |
| 10 | 47 | |
| 11 | 101 | |
| 12 | 86 | |
| 13 | 70 | |
| 14 | 38 | |
| 15 | 9 | |
| 16 | 85 | |
| 17 | 176 | |
| 18 | 90 | |
| 19 | 105 | |
| 20 | Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinomabreakdown → | 794 |
About Britt Skogseid
Britt Skogseid is a scholar working on Neurology, Epidemiology and Oncology, having authored 130 papers that have together received 7.0k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (105 papers), Neuroblastoma Research and Treatments (58 papers) and Lung Cancer Research Studies (46 papers). The work is most often cited by research in Neurology (3.8k citations), Oncology (4.4k citations) and Epidemiology (5.3k citations). Britt Skogseid has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Kjell Öberg, Barbro Eriksson, Catharina Larsson, Göran Åkerström, Magnus Nordenskjöld, Jonas Rastad, Donald Granberg, Yusuke Nakamura, Per Hellman and Erik Wilander. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Endocrine Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.